| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.49 | 0.07 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.3 | 0.08 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 0.08 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.076 | 0.09 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.29 | 0.1 |